Eighty Years of Alaga, Translated Into a Benefits Model
- 2 days ago
- 5 min read
Before You Choose a Corporate Health Benefits Partner in the Philippines, Ask What They Inherited
Every corporate health benefits partner in the Philippines will tell you they care about your people. It is the least differentiating sentence in our industry. The more useful question — the one that actually predicts how a partner will behave three years into a contract, on the day something goes wrong — is narrower and harder to answer.
What did they inherit?
Not what they promise. What they were built out of. Because when a benefits relationship is tested, an organisation does not fall back on its brand values. It falls back on its habits. And habits are inherited.
Alaga is not a slogan we chose
Flexicare operates under Health Delivery System, Inc., within the United Laboratories (Unilab) group. Unilab was founded in 1945 as a small drugstore in war-damaged Binondo, built on a premise that was closer to a civic position than a business plan: quality medicine that ordinary Filipinos could actually afford (Inquirer, 2025).
That is the origin of what the organization calls Alaga — nurturing care. It is worth being precise about what the word carries, because it has been worn thin by marketing.
Alaga is not friendliness. It is custodianship. It describes a duty of care toward someone's quality of life that persists whether or not they are currently sick, and whether or not attending to them is convenient. In a pharmaceutical business, that duty showed up as a pricing discipline. In a benefits business, it shows up somewhere less visible and more consequential: in what happens when a member's claim is complicated, when a diagnosis is unclear, when the answer that is easiest for the administrator is not the answer that is right for the person.
We did not select that value from a workshop. We inherited it, along with the operating expectations that come with it.
Why an eight-decade lineage is a procurement fact, not a sentiment
Here is where legacy stops being a nice story and starts being relevant to a CHRO's decision.
A benefits partner sits between your workforce and the healthcare system at the exact moments your people are least equipped to advocate for themselves. That position carries real asymmetry. Your employee, mid-diagnosis, does not know which questions to ask. Your HR team, mid-quarter, cannot audit every determination. The partner's own restraint is doing most of the work.
Organizations exercise that kind of restraint reliably for one of two reasons: regulation forces them to, or institutional memory makes the alternative unthinkable. Regulation sets a floor. Institutional memory sets the actual standard.
An organisation that has operated inside Philippine healthcare for eight decades has accumulated something a newer entrant cannot buy: knowledge of how this specific system fails. Which regulatory shifts are genuine and which are noise. How provider relationships behave under strain. What a claims process does to a family already under pressure. That knowledge is not a competitive advantage in the marketing sense. It is a reduction in your risk of being surprised.
Flexicare itself has operated within this structure since the late 1990s — first administering the health requirements of the group's own employees and their dependents, and from 2006 extending health benefits administration to outside organisations. Which is a detail worth sitting with: we ran this model on our own people before we offered it to yours.
What the inheritance actually changed in the model
Legacy that does not alter behaviour is decoration. Three specific things follow from ours.
We administer against the person, not the transaction
The pharmaceutical inheritance framed health as a continuing obligation rather than a series of billable events. Carried into benefits administration, that produces a bias toward resolution over closure — toward the outcome for the member rather than the fastest disposal of the case. This is a cultural default, and cultural defaults are the part of a partner you cannot read in a proposal.
We build for regulatory and medical complexity, not around it
Philippine healthcare is a demanding operating environment: multiple regulatory regimes, an uneven provider landscape, and cost pressure that compounds. A partner with a shallow institutional base manages this by narrowing what it will handle. A partner with depth builds the administrative and clinical infrastructure to absorb it. Those two strategies look identical in a pitch and diverge sharply in year three.
We treat scale as a service obligation
Network breadth is usually sold as a number. The number matters only in what it produces: whether an employee in a secondary city has a real option, whether a specialist referral is available before a condition becomes expensive, whether "covered" and "accessible" mean the same thing in practice.
Legacy is not a claim about the past. It is a prediction about behaviour — and it is the only part of a benefits partner you can assess before you need them.
The question to actually ask in a benefits review
Most benefits reviews are structured around coverage and cost. Both are necessary. Neither is sufficient, because both describe the arrangement on a good day.
Add a third line of inquiry. Ask a prospective partner what they were built out of. Ask what they did before they did this. Ask who they answer to and how long that relationship has existed. Ask what happens, structurally, when the commercially convenient decision and the right decision diverge.
You are not asking for a story. You are testing whether there is an institutional reason to expect consistency — because a benefits partner is a multi-year relationship whose value shows up mostly in circumstances no one can anticipate at signing.
The organizations that answer that question well tend to be the ones who inherited an answer. The ones who invented a set of values for a pitch deck tend to reveal it eventually.
Frequently asked questions
What does "Alaga" mean in a corporate benefits context?
Alaga is a Filipino concept of nurturing care that implies ongoing custodianship of someone's wellbeing rather than episodic treatment. Applied to benefits administration, it means designing around what a person needs across their health journey, not only around what is claimable at a given moment.
Why does a benefits provider's corporate lineage matter to an HR decision-maker? Because a benefits partner exercises significant discretion at moments when your employees and your HR team have limited capacity to scrutinise it. Institutional history is one of the few available indicators of how an organisation behaves when that discretion is tested.
What is the relationship between Flexicare, Health Delivery System, Inc., and Unilab? Flexicare operates under Health Delivery System, Inc., within the United Laboratories (Unilab) group. Flexicare has administered health benefits since the late 1990s and began serving external corporate clients in 2006.
How should a CHRO evaluate a benefits partner beyond coverage and price?
Assess institutional depth, regulatory and administrative capability, network accessibility in the locations where your workforce actually lives, and the partner's track record of consistency. Coverage and price describe the arrangement under normal conditions; the rest describes it under strain.
Where to take this next
If you are entering a benefits review, the most useful first step is usually not a comparison of plans. It is a clear-eyed diagnosis of what your workforce actually needs and where your current arrangement is quietly failing them.
That is the conversation we prefer to start with. Book an organizational well-being assessment, and we will work through your workforce profile, your utilization patterns, and the gaps between what you are paying for and what your people are receiving. No quote, no plan comparison — a diagnosis.
Enabling life together
Reference:
Inquirer. (2025). Unilab at 80: Staying the course, shaping the future of Filipino healthcare. Philippine Daily Inquirer.
Comments